Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jude Samulski

Showing results (81-90 of 198) with videos related to

Pageof 20
Sort By:
Current Protocols in Neuroscience|April 23, 2008
Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administrationVivian W Choi, Aravind Asokan, Rebecca A Haberman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2025
AAV vector development, back to the futureLester Suarez-Amaran, Liujiang Song, Anna P Tretiakova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vectorBoris Kantor, Matthew Bayer, Hong Ma, et al.
Glycobiology|June 25, 2004
Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopyAtsuko Negishi, Jinghua Chen, Douglas M McCarty, et al.
European Journal of Immunology|November 19, 2016
β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD miceFatima Manzoor, Mark C Johnson, Chengwen Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2018
Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administrationZheng Chai, Xintao Zhang, Kelly Michelle Rigsbee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2021
"D" matters in recombinant AAV DNA packagingJunping Zhang, Ping Guo, Yinxia Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2022
AAV vectors: The Rubik's cube of human gene therapyAmaury Pupo, Audry Fernández, Siew Hui Low, et al.
Journal of Virology|May 18, 2007
Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virionsJoshua C Grieger, Jarrod S Johnson, Brittney Gurda-Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2007
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transductionJinhui Wang, Jing Xie, Hui Lu, et al.
Pageof 20

Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
Current Protocols in Neuroscience|April 23, 2008
Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administrationVivian W Choi, Aravind Asokan, Rebecca A Haberman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2025
AAV vector development, back to the futureLester Suarez-Amaran, Liujiang Song, Anna P Tretiakova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vectorBoris Kantor, Matthew Bayer, Hong Ma, et al.
Glycobiology|June 25, 2004
Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopyAtsuko Negishi, Jinghua Chen, Douglas M McCarty, et al.
European Journal of Immunology|November 19, 2016
β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD miceFatima Manzoor, Mark C Johnson, Chengwen Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2018
Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administrationZheng Chai, Xintao Zhang, Kelly Michelle Rigsbee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2021
"D" matters in recombinant AAV DNA packagingJunping Zhang, Ping Guo, Yinxia Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2022
AAV vectors: The Rubik's cube of human gene therapyAmaury Pupo, Audry Fernández, Siew Hui Low, et al.
Journal of Virology|May 18, 2007
Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virionsJoshua C Grieger, Jarrod S Johnson, Brittney Gurda-Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2007
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transductionJinhui Wang, Jing Xie, Hui Lu, et al.
Pageof 20